Firm will work with APACHE Medical Systems, Inc. to apply data tracking systems to non-hospital settings under an agreement announced May 5. Caremark has invested $5 mil. for a "minority" equity position in APACHE. The outcomes management systems and consulting firm develops systems to track hospital patient data, including APACHE II (Acute Physiology, Age & Chronic Health Evaluation). Caremark, the largest home infusion company in the U.S., wants to apply the APACHE systems to its business
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth